Ardelyx Inc ARDX

$3.06 -0.06 (-1.92%)

Valuation

Market cap
799,366,000
Revenue TTM
$407,320,000
Net income TTM
$-61,600,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-15.12%
Debt to equity
1.54

Trading

Volume
3,386,500
Avg volume
4,634,706
Day's range
$3.02 – $3.20
Shares out
251,373,000
Stochastic %K
70%
Beta
0.79
Analysts
Strong Buy
Price target
$12.50

Price

Company profile

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, I...

Show more

Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH, a phosphate absorption inhibitor to reduce serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx, Inc. was formerly known as Nteryx, Inc. and changed its name to Ardelyx, Inc. in June 2008. The company was incorporated in 2007 and is headquartered in Waltham, Massachusetts.

Industry
Biotechnology
Sector
Healthcare
Phone
510 745 1700
Website
https://www.ardelyx.com
Address
400 Fifth Avenue, Suite 210, Waltham, United States

Latest news

Stocktwits

Paul_Volcker Nov 19, 10:53 PM
$ARDX I just looked over stock sales - so far this year Raab has sold about $1.9M - sells every month - he still owns about 1.6 million shares and Uncle Mott owns about 3.3 million shares.
1 replies
crypto_biotech Nov 19, 10:40 PM
$ARDX Sage.
0 replies
Vextra Nov 19, 9:13 PM
Look at ticker FGI spiking now. crazy! If you want to be early for once look at FGI 🚀 FGI is just starting lets hope it pulls a OMH 2,000% type of run!! FGI on watch from $HIMX $ARDX //
0 replies
GridironGainz Nov 19, 8:47 PM 0 replies
ToadTrader Nov 19, 8:16 PM
$ARDX Just Hanging out, here at the 303! Anyone have apples?
0 replies
opportoni Nov 19, 7:03 PM
$ARDX 2 green weeks back to back.
0 replies
IMADORK Nov 19, 6:46 PM
$ARDX My hunch is ARDX won’t buy another Bio or an early stage pipeline asset in the near future. Reason is they have put all their eggs in the “Will be profitable in 2027” basket. Repeatedly. Taking on a new asset or company would be an expense and create a new execution risk alongside the current payor friction(unless the new asset is accretive…). Imo until they go profitable and generate large cash flows they won’t bite on other assets. Timing is everything. Doing so now, the market could interpret it as taking eyes off the ball.
0 replies
ToadTrader Nov 19, 6:20 PM
$ARDX Enough said.... I'm not Guessing either way.... Enjoying the coffee.... sunshine.... peace and quiet (Wife went shopping!) CHEERS!
0 replies